Clinical Trials Browser

OTHER × Injections × Breast × Clear all

NCT06009627 2026-02-10

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Phase 2/3 Completed

Breast Neoplasms

NCT07209436 2026-01-22

Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction

Phase NA Recruiting

Breast Neoplasms

NCT06220214 2026-01-15

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04778839 2025-08-06

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Phase 1 Recruiting

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms

NCT07106112 2025-08-06

COMET

Phase NA Recruiting

Breast Neoplasms

NCT06172127 2025-07-29

DEMETHER

Phase 2 Recruiting

Breast Neoplasms

NCT06199895 2025-06-03

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Phase 2 Recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05332561 2025-03-20

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Phase 2 Recruiting

Breast Neoplasms

NCT05711030 2024-02-20

TPVB

Phase NA Unknown

Breast Neoplasms

NCT04431674 2023-12-13

USmBRT-B

Phase 1 Completed

Breast Neoplasms

NCT03121989 2023-03-30

LABC

Phase 1 Withdrawn

Breast Neoplasms

NCT02652923 2023-01-23

Contrast Ultrasound Detection of Sentinel Lymph Nodes

Phase 1/2 Completed

Breast Neoplasms

NCT05560308 2022-10-03

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Phase NA Unknown

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

Breast Neoplasms

NCT03139851 2021-09-10

CHEMOIMMUNE

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT03203616 2018-11-29

KIARA

Phase 2 Withdrawn

Metastatic HER2-positive Breast Cancer With Brain Metastasis

NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Phase 2 Unknown

Breast Neoplasms

NCT01765309 2013-01-14

A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders

Phase NA Completed

Breast Neoplasms

NCT01428414 2012-08-23

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00955890 2012-02-28

cardioprotec

Phase 2 Terminated

Breast Neoplasms